GlaxoSmithKline Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | NSE: GLAXO | BSE: 500660

₹2,508.80 image-60.65 (-2.36 %)

Last Updated: 21 Feb 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 2,583.15

High (₹) 2,586.00

Low (₹) 2,487.55

Prev. Close (₹) 2,569.45

Volume 10,554

VWAP (₹) 2,543.15

ROCE (%) 47.33

Industry P/E 43.99

TTM P/E 49.46

P/B Ratio 23.91

Market Cap (₹) Cr.42,498.89

Dividend Yield (%)1.28

EPS (₹) 34.83

ROE33.19%

Sales Growth (%) 6.21

Profit Growth (%)-3.39

Day Range

2,586.002,586.00

L
H

52 Week Range

1,825.053,087.95

L
H

Historical Returns

Returns (6M)

-13.65 %

Returns (1Y)

15.67 %

Returns (3Y)

60.41 %

Returns (5Y)

87.42 %

Returns (6M)

-13.65 %

Returns (1Y)

15.67 %

Returns (3Y)

60.41 %

Returns (5Y)

87.42 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with no debt
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • High CCI indicates strong upward momentum.
  • Positive ROC (9) indicates upward momentum.
  • Strong trend indicated by ADX above 25.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 76.24

MFI 84.15

ATR 155.16

Commodity Channel Index 143.19

ROC125 -14.79

ROC21 19.83

Williams %R -29.70

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current2,567.352,625.902,665.802,527.452,468.902,429.002,370.45
Week Ago2,049.162,080.582,121.162,008.581,977.161,936.581,905.16
Month Ago2,188.802,235.502,270.502,153.802,107.102,072.102,025.40

EMA & SMA
info_icon

2508.80

Current Price

EMA & SMApin

Bullish Moving Averages

20

Bearish Moving Averages

0

5 Day 2437.47


9 Day 2238.06


10 Day 2246.08


12 Day 2206.88


14 Day 2187.69

20 Day 2139.44


26 Day 2140.73


50 Day 2182.71


100 Day 2377.66


200 Day 2496.27

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES INDIA SC MAURITIUS COMPANYblockSell17 Oct, 2022₹1,378.6511,841BSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell17 Oct, 2022₹1,378.6580,615BSE
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy17 Oct, 2022₹1,378.6511,841BSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy17 Oct, 2022₹1,378.6580,615BSE
ISHARES INDIA SC MAURITIUS COMPANYblockSell11 Oct, 2022₹1,393.4511,417BSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell11 Oct, 2022₹1,393.4577,734BSE
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy11 Oct, 2022₹1,393.4511,417BSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy11 Oct, 2022₹1,393.4577,734BSE
ISHARES INDIA SC MAURITIUS COMPANYblockSell19 Sept, 2022₹1,431.7510,499BSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell19 Sept, 2022₹1,431.7572,154BSE

Insider Trading

No insider trading details available.

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
24 Oct, 2024Rs.12.0000 per share(120%)Interim Dividend07 Nov, 202407 Nov, 2024
17 May, 2024Rs.32.0000 per share(320%)Final Dividend31 May, 202431 May, 2024
17 May, 2023Rs.32.0000 per share(320%)Final Dividend30 Jun, 202330 Jun, 2023

Announcements

DateSourceDetail
18 Feb, 2025NSE IndiaGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
18 Feb, 2025BSE IndiaAs per attachment
17 Feb, 2025NSE IndiaGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
17 Feb, 2025NSE IndiaGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
17 Feb, 2025BSE IndiaTranscript of Analyst Meet
15 Feb, 2025BSE Indiaas per attachment
15 Feb, 2025NSE IndiaGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording
14 Feb, 2025NSE IndiaGLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
14 Feb, 2025BSE IndiaRevsied outcome of meeting
14 Feb, 2025NSE IndiaGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 14, 2025.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results(Revised)21 Jan, 202514 Feb, 2025
Quarterly Results(Cancelled)21 Jan, 202510 Feb, 2025
Quarterly Results & Interim Dividend--25 Oct, 202429 Oct, 2024
Quarterly Results--19 Jul, 202402 Aug, 2024
Audited Results & Final Dividend--22 Apr, 202417 May, 2024
Quarterly Results--05 Jan, 202412 Feb, 2024
Quarterly Results--05 Oct, 202309 Nov, 2023
Quarterly Results--03 Jul, 202326 Jul, 2023
Audited Results & Final Dividend--04 May, 202317 May, 2023
Quarterly Results--12 Jan, 202307 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3407.25 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

MNC Associate

Founded

1924

Managing Director

Mr. B Akshikar

NSE Symbol

GLAXO

GlaxoSmithKline Pharmaceuticals Management

NameDesignation
Ms. R S KarnadChairperson
Mr. B AkshikarManaging Director
Mr. J ChandyWholeTime Director & CFO
Mr. S WilliamsNon Executive Director
Mr. M AnandIndependent Director
Dr.(Ms.) S MaheshwariIndependent Director
Mr. A N RoyIndependent Director
Mr. D SundaramIndependent Director
Mr. P V BhideIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,643.75 image
₹1,669.30(-1.53%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,757.05 image
₹5,978.30(-3.70%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,475.75 image
₹1,479.70(-0.27%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,327.75 image
₹2,348.45(-0.88%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,151.80 image
₹1,170.95(-1.64%)
₹1,104.690 - ₹1,420.200

FAQs on GlaxoSmithKline Pharmaceuticals

What is the share price of GlaxoSmithKline Pharmaceuticals?

The share price of GlaxoSmithKline Pharmaceuticals on 21 Feb, 2025 is ₹ 2,508.80.

What is 52W high and 52W low share price of GlaxoSmithKline Pharmaceuticals?

The highest and lowest 52W share prices of GlaxoSmithKline Pharmaceuticals are ₹ 3087.950 and ₹ 1799.050

What is the market cap of GlaxoSmithKline Pharmaceuticals?

The market capitalization of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is ₹ 42,498.89 Crores

What is the P/E ratio of GlaxoSmithKline Pharmaceuticals?

The current P/E ratio of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is 43.99

What is the PB ratio of GlaxoSmithKline Pharmaceuticals?

The PB ratio of GlaxoSmithKline Pharmaceuticals as of 21 Feb, 2025 is 23.91

Top Gainers

948IHFL26I

IBHFL NCD186

₹845.00image

₹705.00 (0.20%)

GREAVESCOT

Greaves

₹281.85image

₹234.90 (0.20%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.20%)

CAPRO

Caprola.Chem

₹62.40image

₹52.00 (0.20%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.10%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.10%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0.00%)

Source : Dion Global Solutions Limited